Description: An overview of the Medicare Supplement landscape and the critical factors for successfully pricing and managing this product line amidst the challenges that exist.

Description: This discussion at the SOA 2000 Las Vegas Spring Meeting focuses on the polictical landscape with respect to health care issues including Medicare, prescription drug coverage, the concept of a patient's 'bill of rights', and other health care reform ideas.

Description: From a session at the Health/Pension Spring Meeting held in New Orleans, Louisiana June 15-17, 2005 Panelists discuss how the regulatory environment is being reactive and proactive to improve affordability in the market.

Description: This article describes the pre-HIPAA small group market and identify some of the key changes to this market resulting from HIPAA particularly guaranteed issue and renewal and restriction of pre-existing conditions and.

Description: This session discussion is about personal risk and social responsibility. From Record of the Society of Actuaries Vol. 15, No. 1

Description: The article describes the Health Sections strategic initiative for Public Health and the role of the actuary.

Description: Overview of public health (responsibilities, funding, challenges) and discussion of the role actuaries can play in achieving population health goals.

Description: At this presentation from Session 72D of the SOA 1996 Colorado Springs Meeting, the panelists debate legislative changes to the Medicare program. Included is an overview of the changes in the 1995 legislation, expected savings in the Federal budget, a debate as to the realism of these expected savings, reaction of enrollees, and a discussion of anticipated effects on the private sector of the healthcare system. From the Record of the Society of Actuaries, Vol. 22, No. 2.

Description: This discussion presents a few comments on the legislative situation with regard to health care for the aged in the United States. From Transactions of Society of Actuaries 1961, Vol. 13, No. 37.

Description: Savings from biosimilars have accelerated significantly in the past few years. There has been a number of relatively recent biosimilar launches that can help to shape our expectations of the financial impact that could result from this year’s big event. Savings from biosimilars have accelerated significantly in the past few years. There has been a number of relatively recent biosimilar launches that can help to shape our expectations of the financial impact that could result from this year’s big event.